NPPA Fixes Retail Prices of Key Combination Drugs Exclusive of GST

Last updated: 17 September 2025


Quick Summary
The National Pharmaceutical Pricing Authority (NPPA) has established maximum retail prices (MRPs) for several important combination drug formulations, including those for pain relief and diabetes. These prices, effective from September 15, 2025, are set exclusive of Goods and Services Tax (GST). This initiative aims to make essential medicines more affordable and bring transparency to the pharmaceutical market, with penalties in place for non-compliance.

The National Pharmaceutical Pricing Authority (NPPA) has notified the retail prices of several new drug formulations, including widely prescribed combinations for pain relief and diabetes management. The order, issued on September 15, 2025, under the Drugs (Prices Control) Order, 2013 (DPCO), fixes
Daily Limit Reached

You have reached your daily limit of 2 Free News

Subscribe to CCI PRO for unlimited access

Why Upgrade to CCI PRO?
  • No Ads
  • WhatsApp Broadcasts
  • Daily E-Newsletter
  • Unlimited News Access
BEST VALUE
2 YEAR PLAN
3,499
(Inclusive of GST)
1 YEAR PLAN
1,999
(Inclusive of GST)
Buy CCI PRO Now

Already a PRO member? Login here for an ad-free experience.

FAQ :

The NPPA has fixed the maximum retail prices (MRPs) for several new drug formulations, particularly combination drugs used for pain relief and diabetes management.

The maximum retail prices fixed by the NPPA are exclusive of Goods and Services Tax (GST). Manufacturers can add GST only if it is payable.

Examples include Aceclofenac, Paracetamol & Thiocolchicoside tablets, Ibuprofen & Paracetamol suspension, and various combinations of Dapagliflozin, Glimepiride, Metformin, Sitagliptin, and Empagliflozin.

Any violation, including overcharging, will result in the recovery of the overcharged amount along with interest, as per the Essential Commodities Act, 1955.

The move is intended to prevent the overpricing of essential combination drugs, ensuring affordability and transparency in the pharmaceutical market for patients managing chronic conditions.




News posted by

Finance news reporter covering taxation, GST, income tax, business compliance, and economy updates. I simplify complex financial topics into easy-to-understand articles for professionals, taxpayers, and business owners on leading finance and tax platforms.

Click here to Login and post comments    OR



More »


Popular News





CCI Pro



Company
ARTICLESHIP 16 July 2026
Article Assistant

G A R U D & Associates

New Delhi

CA Inter

View Details
Company
06 July 2026
Chartered Accountant (Indirect Taxation)

Gowra Ventures Pvt Ltd

Hyderabad

CA

View Details
Company
ARTICLESHIP 28 June 2026
Article Assistant

Sharma Chetan And Company

Gurgaon

CA Inter

View Details
Company
Featured 18 July 2026
Senior Manager- Finance & Accounts

apricus india

Ahmedabad

CA

View Details
Company
ARTICLESHIP 08 July 2026
Article internship

AJAY SINGH AND CO LLP

Thane

CA Final

View Details
Company
06 July 2026
Senior Accountant

Arvindkumar Maniar & Co.

Rajkot

CA

View Details
Company
ARTICLESHIP 07 July 2026
Articleship

Jawahar and Associates Chartered Accountants

Hyderabad

CA Inter

View Details
Company
29 June 2026
Accountant (Finance & Compliance)

TRIEYEZ

Kolkata

CA

View Details